Randomized Comparison of Skeletonized Versus Pedicled Left Internal Thoracic Artery
HARVITA
Randomized Comparison of HARVesting the Left Internal Thoracic Artery in a Skeletonized Versus Pedicled Technique: the HARVITA Trial
1 other identifier
interventional
1,350
3 countries
8
Brief Summary
Internal thoracic arteries can be harvested in skeletonized or pedicled technique. Latest research has posed a potential adverse effect of skeletonizing the internal thoracic arteries on graft patency rates and clinical outcome. Prospective, randomized, multi-centre trials are necessary to investigate the impact of harvesting technique of left internal thoracic artery (LITA) on graft patency rates and clinical outcome after coronary artery bypass grafting. The HARVITA trial compares skeletonized and pedicled harvesting technique of LITA regarding graft patency rates and patient survival.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable coronary-artery-disease
Started Mar 2024
Longer than P75 for not_applicable coronary-artery-disease
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 22, 2023
CompletedFirst Posted
Study publicly available on registry
July 5, 2023
CompletedStudy Start
First participant enrolled
March 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2031
March 15, 2024
June 1, 2023
4.6 years
June 22, 2023
March 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Death or LITA graft occlusion in cCTA or invasive angiography within 2 years (+/- 3 months) after surgery.
The primary endpoint will be compared between the two treatment groups using Kaplan-Meier graphs and a center stratified two sample log-rank test. In addition, Cox proportional hazards regression analysis adjusting for clinically relevant confounders will be performed. Hazard ratios and their 95% confidence intervals will be estimated. LITA graft occlusion is defined as the absence of contrast detection in the lumen of the graft indicating a 100% occlusion of LITA graft.
2 years (+/- 3 months) after surgery
Secondary Outcomes (1)
composite outcome of all-cause death, myocardial infarction and repeated revascularization
1 year, 2 years and 5 years after surgery
Study Arms (2)
skeletonized harvesting technique
ACTIVE COMPARATORIn skeletonized harvesting technique, only the left internal artery itself is harvested.
pedicled harvesting technique
ACTIVE COMPARATORIn pedicled harvesting technique the left internal thoracic artery, it's accompanying veins and parts of the endothoracic fascia is harvested, creating a 1-2 cm broad pedicle.
Interventions
In patients who are randomized to this treatment arm, the left internal thoracic artery will be harvested in skeletonized technique. Thereby, only the artery itself is harvested.
In patients who are randomized to this treatment arm, the left internal thoracic artery will be harvested in pedicled technique. Thereby, the artery will be harvested together with the accompanying veins, the endothoracic fascia and fatty tissue in order to create an 1-2 cm broad pedicle.
Eligibility Criteria
You may qualify if:
- Primary isolated CABG patients with multi-vessel disease (defined as ≥70 % stenosis of the left anterior descending artery (LAD) and ≥50% stenosis of circumflex and right coronary territory, with or without a ≥50% stenosis of the left main artery).
You may not qualify if:
- Age \> 80 years
- Planned CABG without LITA use
- Preoperative mediastinal radiation therapy
- Emergency operation
- Minimal invasive coronary artery bypass surgery
- Any concomitant cardiac or non-cardiac procedures
- Previous cardiac surgery
- Known contrast agent allergy
- Severe stenosis of the left subclavian artery/ left-sided subclavian steal syndrome
- Chronic kidney disease (GFR \<60ml/min/1.73m²)
- Life expectancy of less than 5 years
- Pregnancy
- Hyperthyroidism
- Iodine allergy
- Y/T graft off the LITA graft
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
Medical University of Graz
Graz, Austria
Medical University of Innsbruck
Innsbruck, Austria
Medical University of Vienna
Vienna, Austria
University of Duisburg-Essen
Essen, Germany
University of Freiburg
Freiburg im Breisgau, Germany
University Hospital Gießen
Giessen, Germany
University of Jena
Jena, Germany
University Hospital Bern
Bern, Switzerland
Related Publications (2)
Lamy A, Browne A, Sheth T, Zheng Z, Dagenais F, Noiseux N, Chen X, Bakaeen FG, Brtko M, Stevens LM, Alboom M, Lee SF, Copland I, Salim Y, Eikelboom J; COMPASS Investigators. Skeletonized vs Pedicled Internal Mammary Artery Graft Harvesting in Coronary Artery Bypass Surgery: A Post Hoc Analysis From the COMPASS Trial. JAMA Cardiol. 2021 Sep 1;6(9):1042-1049. doi: 10.1001/jamacardio.2021.1686.
PMID: 34132753BACKGROUNDGaudino M, Audisio K, Rahouma M, Chadow D, Cancelli G, Soletti GJ, Gray A, Lees B, Gerry S, Benedetto U, Flather M, Taggart DP; ART Investigators. Comparison of Long-term Clinical Outcomes of Skeletonized vs Pedicled Internal Thoracic Artery Harvesting Techniques in the Arterial Revascularization Trial. JAMA Cardiol. 2021 Dec 1;6(12):1380-1386. doi: 10.1001/jamacardio.2021.3866.
PMID: 34586338BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hannes Abfalterer, Dr. med. univ.
Medical University Innsbruck
- PRINCIPAL INVESTIGATOR
Nikolaos Bonaros, Univ. Prof. Dr.
Medical University Innsbruck
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 22, 2023
First Posted
July 5, 2023
Study Start
March 12, 2024
Primary Completion (Estimated)
October 1, 2028
Study Completion (Estimated)
October 1, 2031
Last Updated
March 15, 2024
Record last verified: 2023-06